Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental setting

Rituximab has broad and increasing application in rheumatic diseases. It is known from lymphoma studies that natural killer (NK) cells can lyse rituximab-coated transformed B cells. However, the role of NK cel...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Source Type: research